CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 575 of 1467 entries

View as:

Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic Dermatitis

Phase: N/A Priority: Normal

NCT ID: NCT06039241 Org: User:

Start: 03/07/23 End: 03/08/27 Due: 03/08/28

Obese Patients With Untreated Dyslipidemias

Phase: N/A Priority: Normal

NCT ID: NCT00029835 Org: User:

Start: 09/30/01 End: 11/30/03 Due: 11/30/04

Immunogenicity and Safety of Pentaxim in South African Infants

Phase: N/A Priority: Normal

NCT ID: NCT00254969 Org: User:

Start: 10/31/05 End: 01/31/10 Due: 01/31/11

Comparative Efficacy of Cemiplimab to Historical Standard of Care in France

Phase: N/A Priority: Normal

NCT ID: NCT05302297 Org: User:

Start: 01/17/22 End: 09/30/22 Due: 09/30/23

Riluzole in Huntington's Disease

Phase: N/A Priority: Normal

NCT ID: NCT00277602 Org: User:

Start: 11/30/99 End: 07/31/04 Due: 07/31/05

Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction

Phase: N/A Priority: Normal

NCT ID: NCT00670228 Org: User:

Start: 04/30/08 End: 11/30/09 Due: 11/30/10

Dermacyd in Odor Reducing.

Phase: N/A Priority: Normal

NCT ID: NCT01158365 Org: User:

Start: 07/31/10 End: 12/31/10 Due: 12/31/11

A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps

Phase: N/A Priority: Normal

NCT ID: NCT06834347 Org: User:

Start: 02/12/25 End: 12/13/27 Due: 12/13/28

Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT00452725 Org: User:

Start: 10/31/97 End: 07/31/10 Due: 07/31/11

Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)

Phase: N/A Priority: Normal

NCT ID: NCT06191315 Org: User:

Start: 01/03/24 End: 12/21/28 Due: 12/21/29

High Density Lipoprotein Turnover

Phase: N/A Priority: Normal

NCT ID: NCT00408148 Org: User:

Start: 10/31/06 End: 12/31/08 Due: 12/31/09

Ibuprofen Versus Ibuprofen Plus Caffeine in the Treatment of Migraine.

Phase: N/A Priority: Normal

NCT ID: NCT01426971 Org: User:

Start: 12/31/12 End: 06/30/13 Due: 06/30/14

Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin

Phase: N/A Priority: Normal

NCT ID: NCT00135057 Org: User:

Start: 04/30/04 End: 08/31/05 Due: 08/31/06

Role of Xaliproden on Recovery Rate From Severe Neuropathy in Patients Who Have Completed Adjuvant Chemotherapy With Oxaliplatin Based Regimens

Phase: N/A Priority: Normal

NCT ID: NCT00603577 Org: User:

Start: 01/31/08 End: 11/30/09 Due: 11/30/10

Insulin Glulisine, Diabetes Mellitus Type 1

Phase: N/A Priority: Normal

NCT ID: NCT00397553 Org: User:

Start: 01/31/05 End: - Due: -

A Study to Observe How Insulin Glargine 300 U/ml is Working and is Tolerated in Elderly Patients ≥75 Years of Age With Type 2 Diabetes

Phase: N/A Priority: Normal

NCT ID: NCT05607160 Org: User:

Start: 10/05/22 End: 12/11/23 Due: 12/11/24

A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

Phase: N/A Priority: Normal

NCT ID: NCT06280391 Org: User:

Start: 02/20/24 End: 08/11/26 Due: 08/11/27

A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®)

Phase: N/A Priority: Normal

NCT ID: NCT05070663 Org: User:

Start: 11/04/21 End: 03/03/25 Due: 03/03/26

A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients

Phase: N/A Priority: Normal

NCT ID: NCT00479076 Org: User:

Start: 03/31/07 End: 01/31/11 Due: 01/31/12

Study of How Single Rising Doses of SAR161271 Are Absorbed and Act in Patients With Type 1 Diabetes Mellitus (T1DM)

Phase: N/A Priority: Normal

NCT ID: NCT01053728 Org: User:

Start: 02/28/10 End: 11/30/10 Due: 11/30/11

Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Phase: N/A Priority: Normal

NCT ID: NCT00104013 Org: User:

Start: 11/30/03 End: 11/30/07 Due: 11/30/08

Efficacy and Safety of FIRTECH in Patients With Mild to Moderate Acute Low Back Pain

Phase: N/A Priority: Normal

NCT ID: NCT05137041 Org: User:

Start: 11/04/21 End: 11/22/22 Due: 11/22/23

Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain

Phase: N/A Priority: Normal

NCT ID: NCT01463397 Org: User:

Start: 03/31/12 End: 05/31/13 Due: 05/31/14

Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00160030 Org: User:

Start: 09/30/04 End: - Due: -

Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine

Phase: N/A Priority: Normal

NCT ID: NCT02273180 Org: User:

Start: 10/31/14 End: 07/31/16 Due: 07/31/17

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic Dermatitis	NCT06039241	Sanofi	user2@example.com	None	2023-03-07	2027-03-08	2028-03-08	-	-	2025-07-14
Obese Patients With Untreated Dyslipidemias	NCT00029835	Sanofi	user2@example.com	None	2001-09-30	2003-11-30	2004-11-30	-	-	2025-07-14
Immunogenicity and Safety of Pentaxim in South African Infants	NCT00254969	Sanofi	user2@example.com	None	2005-10-31	2010-01-31	2011-01-31	-	-	2025-07-14
Comparative Efficacy of Cemiplimab to Historical Standard of Care in France	NCT05302297	Sanofi	user2@example.com	None	2022-01-17	2022-09-30	2023-09-30	-	-	2025-07-14
Riluzole in Huntington's Disease	NCT00277602	Sanofi	user2@example.com	None	1999-11-30	2004-07-31	2005-07-31	-	-	2025-07-14
Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction	NCT00670228	Sanofi	user2@example.com	None	2008-04-30	2009-11-30	2010-11-30	-	-	2025-07-14
Dermacyd in Odor Reducing.	NCT01158365	Sanofi	user2@example.com	None	2010-07-31	2010-12-31	2011-12-31	-	-	2025-07-14
A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps	NCT06834347	Sanofi	user2@example.com	None	2025-02-12	2027-12-13	2028-12-13	-	-	2025-07-14
Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome	NCT00452725	Sanofi	user2@example.com	None	1997-10-31	2010-07-31	2011-07-31	-	-	2025-07-14
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)	NCT06191315	Sanofi	user2@example.com	None	2024-01-03	2028-12-21	2029-12-21	-	-	2025-07-14
High Density Lipoprotein Turnover	NCT00408148	Sanofi	user2@example.com	None	2006-10-31	2008-12-31	2009-12-31	-	-	2025-07-14
Ibuprofen Versus Ibuprofen Plus Caffeine in the Treatment of Migraine.	NCT01426971	Sanofi	user2@example.com	None	2012-12-31	2013-06-30	2014-06-30	-	-	2025-07-14
Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin	NCT00135057	Sanofi	user2@example.com	None	2004-04-30	2005-08-31	2006-08-31	-	-	2025-07-14
Role of Xaliproden on Recovery Rate From Severe Neuropathy in Patients Who Have Completed Adjuvant Chemotherapy With Oxaliplatin Based Regimens	NCT00603577	Sanofi	user2@example.com	None	2008-01-31	2009-11-30	2010-11-30	-	-	2025-07-14
Insulin Glulisine, Diabetes Mellitus Type 1	NCT00397553	Sanofi	user2@example.com	None	2005-01-31	-	-	-	-	2025-07-14
A Study to Observe How Insulin Glargine 300 U/ml is Working and is Tolerated in Elderly Patients ≥75 Years of Age With Type 2 Diabetes	NCT05607160	Sanofi	user2@example.com	None	2022-10-05	2023-12-11	2024-12-11	-	-	2025-07-14
A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis	NCT06280391	Sanofi	user2@example.com	None	2024-02-20	2026-08-11	2027-08-11	-	-	2025-07-14
A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®)	NCT05070663	Sanofi	user2@example.com	None	2021-11-04	2025-03-03	2026-03-03	-	-	2025-07-14
A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients	NCT00479076	Sanofi	user2@example.com	None	2007-03-31	2011-01-31	2012-01-31	-	-	2025-07-14
Study of How Single Rising Doses of SAR161271 Are Absorbed and Act in Patients With Type 1 Diabetes Mellitus (T1DM)	NCT01053728	Sanofi	user2@example.com	None	2010-02-28	2010-11-30	2011-11-30	-	-	2025-07-14
Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type	NCT00104013	Sanofi	user2@example.com	None	2003-11-30	2007-11-30	2008-11-30	-	-	2025-07-14
Efficacy and Safety of FIRTECH in Patients With Mild to Moderate Acute Low Back Pain	NCT05137041	Sanofi	user2@example.com	None	2021-11-04	2022-11-22	2023-11-22	-	-	2025-07-14
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain	NCT01463397	Sanofi	user2@example.com	None	2012-03-31	2013-05-31	2014-05-31	-	-	2025-07-14
Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer	NCT00160030	Sanofi	user2@example.com	None	2004-09-30	-	-	-	-	2025-07-14
Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine	NCT02273180	Sanofi	user2@example.com	None	2014-10-31	2016-07-31	2017-07-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance